> Netherlands-based Pepscan Systems, a peptide based immunotherapy company, announced today that it has raised $9 million in a second financing round by issuance of equity to a group of Dutch investors. Release
> Chutes & Ladders: Dr. Jim A. Wright will step down as the President and CEO of Lorus Therapeutics on September 21st. Report
> Novartis has received additional approvals for Glivec in the EU. The approvals cover a rapidly progressive form of leukemia and a hard-to-treat solid cancer tumor. Report
> Opexa has kicked off a Phase IIb study of Tovaxin for the treatment of multiple sclerosis. Report
And Finally... Pfizer is going to court to try to keep the lid on Dr. Peter Rost's The Whistblower: Confessions of a Healthcare Hitman. Release